Henry Uppal

Bachelor of Medicine and Bachelor of Science,  Charité - Universitätsmedizin Berlin 

Location: Africa

Consulting Services

IT-Web-Mobile Technology Biostatistics Legal Support Case Consulting Admin and Customer Support

Areas Of Interest

Centaurea Hypoxia-Inducible Factor-Proline Dioxygenase Periostitis Hygromas NAD+ ADP-Ribosyltransferase Nomascus Parental Leave Dipalmitoylglycerophosphocholine Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency Insect Control Primulaceae Anaprilin Membranes, Bowman's Junction, Neuroeffector Nalbuphine Serb Preparations, Prosthodontic Tooth Handoffs, Patient Fund, Philanthropic Inner Segment, Cone Tumor Stem Cells Twentieth Century Histories Ringer's Solution, Lactated Activin Receptor Like Kinases, Type I Leukemia, Granulocytic, Chronic Phase PtcO2 Real World Clinical Trials Roundworm Infection, Raccoon MCM2 7 Complex Intracranial CNS Disorders Diphenhydramine Theoclate Immunoglobulins, Antilymphocyte Marek's Disease-like Viruses Population Explosion Medical Preference Misdiagnosis Cléridium

Professional Narrative

Dr. Henry Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 1991
Medical Writer, Harvard Med 2017

Education

Doctor of medicine, Perelman School of Medicine 2010
Doctor of osteopathic medicine, Yale School of Medicine 1988

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :